Tel.: +55 11 4301-3714 / 4301-3715


BonAlive Granules

BonAlive Granules’s registry



The first approval for BonAlive® (CE-mark) was in 2004, followed by an extension of the indications in 2006. In 2008 the product received U.S. approval and 510K Clearances.

In 03/28/2011 Anvisa authorized the sale of BonAlive® in Brazil, publishing the product registration number (80625390001) in the Official Journal.

Click on the images below or open the files available in PDF.

You may also visit the link below to search on Anvisa’s website, there you can inform the name of the product (BONALIVE) and the registration number:

You can also visit the  National Press website, by typing the date of publication or edition number  to view the approval of BonAlive® in Official Journal (Suplemento No. 59, segunda-feira, 28 de março de 2011, pág. 21):

Todos os Direitos Reservados © | Ossis Medical 2013
Desenvolvido por Estudio Paladino